To The Moon
Home
News
TigerAI
Log In
Sign Up
Shanghai Kaibao Pharmaceutical Co.,Ltd.(300039)
5.89
-0.19
-3.12%
Market data delayed 15 minutes
Community
Community
News
News
Profile
Profile
Announcements
Announcements
No Content
Company Profile
Company Name
上海凯宝药业股份有限公司
Industry
医药制造业
Listing Date
2010-01-08
Registered Capital
104600万元
Introduction
上海凯宝药业股份有限公司的主营业务是现代中药研发、生产、销售。公司的主要产品是痰热清注射液。报告期内,公司荣获“中国医药市场药企排行榜(中药)2024中国医药市场药企排行榜(中药)TOP100”“2025中国中药研发实力前50强”“奉贤区2024年度财富百强企业”“2024年度上海市工业综合开发区年度影响力传播奖”“奉贤区劳模工匠育人实践基地”等荣誉称号。
1D
5D
Day
Week
Month
Loading ...
High
6.09
Open
6.01
T/O Rate
1.86%
Low
5.87
Close
6.08
Amplitude
3.62%
Most Discussed
{"pagemeta":{"title":"Shanghai Kaibao Pharmaceutical Co.,Ltd.(300039),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","description":"Find the latest Shanghai Kaibao Pharmaceutical Co.,Ltd.(300039) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","keywords":"Shanghai Kaibao Pharmaceutical Co.,Ltd.,300039,Shanghai Kaibao Pharmaceutical Co.,Ltd.股票,Shanghai Kaibao Pharmaceutical Co.,Ltd.股票老虎,Shanghai Kaibao Pharmaceutical Co.,Ltd.股票老虎国际,Shanghai Kaibao Pharmaceutical Co.,Ltd.行情,Shanghai Kaibao Pharmaceutical Co.,Ltd.股票行情,Shanghai Kaibao Pharmaceutical Co.,Ltd.股价,Shanghai Kaibao Pharmaceutical Co.,Ltd.股市,Shanghai Kaibao Pharmaceutical Co.,Ltd.股票价格,Shanghai Kaibao Pharmaceutical Co.,Ltd.股票交易,Shanghai Kaibao Pharmaceutical Co.,Ltd.股票购买,Shanghai Kaibao Pharmaceutical Co.,Ltd.股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Shanghai Kaibao Pharmaceutical Co.,Ltd.(300039),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","og_description":"Find the latest Shanghai Kaibao Pharmaceutical Co.,Ltd.(300039) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","og_image":"https://community-static.tradeup.com/news/9b6dafd60190235ae8e2c95f52c583a0"}},"tab":"community","symbol":"300039","data":{"stockData":{"symbol":"300039","market":"SZ","secType":"STK","nameCN":"Shanghai Kaibao Pharmaceutical Co.,Ltd.","latestPrice":5.89,"timestamp":1775199834000,"preClose":6.08,"halted":0,"volume":17078010,"delay":0,"changeRate":-0.0313,"floatShares":917000000,"shares":1046000000,"eps":0.3304,"marketStatus":"Closed","change":-0.19,"latestTime":"04-03 15:00:00","open":6.01,"high":6.09,"low":5.87,"amount":102000000,"amplitude":0.0362,"askPrice":5.89,"askSize":219,"bidPrice":5.88,"bidSize":1009,"shortable":0,"etf":0,"ttmEps":0.3304,"tradingStatus":0,"nextMarketStatus":{"tag":"Open","tradingStatus":2,"beginTime":1775525400000},"marketStatusCode":5,"adr":0,"adjPreClose":6.08,"symbolType":"stock","openAndCloseTimeList":[[1775179800000,1775187000000],[1775192400000,1775199600000]],"highLimit":6.69,"lowLimit":5.47,"ibTradeSell":false,"ibTradeBuySell":false,"totalEquity":1046000000,"isCdr":false,"pbRate":1.4,"roa":"--","peRate":17.826877,"roe":"10.79%","epsLYR":0.3591,"committee":0.148063,"marketValue":6161000000,"turnoverRate":0.0186,"status":1,"floatMarketCap":5401000000},"tweetData":{"bottom":true,"list":[],"size":0},"newsData":null,"noticeData":{"listData":[],"currentPage":1,"bottom":true},"companyData":{"profile":null,"aProfile":{"ret":0,"listingDate":"2010-01-08","address":"上海市奉贤区工业综合开发区程普路88号","stockEarnings":[{"period":"1week","weight":-0.0051},{"period":"1month","weight":-0.05},{"period":"3month","weight":-0.0232},{"period":"6month","weight":-0.0252},{"period":"1year","weight":-0.094},{"period":"ytd","weight":-0.0232}],"companyName":"上海凯宝药业股份有限公司","boardCode":"AI0027","perCapita":"18586股","boardName":"医药制造业","registeredCapital":"104600万元","compareEarnings":[{"period":"1week","weight":-0.0086},{"period":"1month","weight":-0.0496},{"period":"3month","weight":-0.0224},{"period":"6month","weight":-0.0007},{"period":"1year","weight":0.161},{"period":"ytd","weight":-0.0224}],"survey":" 上海凯宝药业股份有限公司的主营业务是现代中药研发、生产、销售。公司的主要产品是痰热清注射液。报告期内,公司荣获“中国医药市场药企排行榜(中药)2024中国医药市场药企排行榜(中药)TOP100”“2025中国中药研发实力前50强”“奉贤区2024年度财富百强企业”“2024年度上海市工业综合开发区年度影响力传播奖”“奉贤区劳模工匠育人实践基地”等荣誉称号。","serverTime":1775290725840,"listedPrice":38,"stockholders":"49334人(较上一季度减少6.04%)","compareStock":{"symbol":"000001.SH","name":"SSE Comp"}}}}}